(19)
(11) EP 4 422 739 A1

(12)

(43) Date of publication:
04.09.2024 Bulletin 2024/36

(21) Application number: 22821713.9

(22) Date of filing: 28.10.2022
(51) International Patent Classification (IPC): 
A61M 60/829(2021.01)
(52) Cooperative Patent Classification (CPC):
A61M 60/829
(86) International application number:
PCT/US2022/048229
(87) International publication number:
WO 2023/076603 (04.05.2023 Gazette 2023/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 29.10.2021 US 202163273424 P

(71) Applicant: Abiomed, Inc.
Danvers, MA 01923 (US)

(72) Inventors:
  • STACEY, Gary
    Danvers, MA 01923 (US)
  • DAS, Soumen
    Danvers, MA 01923 (US)
  • CORBETT, Scott C.
    Danvers, MA 01923 (US)
  • GABRIEL, James
    Danvers, MA 01923 (US)
  • SHIP, Alexander
    Danvers, MA 01923 (US)

(74) Representative: Klunker IP Patentanwälte PartG mbB 
Destouchesstraße 68
80796 München
80796 München (DE)

   


(54) CONTROLLED PURGE RECOVERY USING TISSUE PLASMINOGEN ACTIVATOR (TPA)